DefiniGEN’s iPS Differentiation service utilizes our proprietary OptiDIFF platform to generate high functionality terminally differentiated custom cell products to fit client specifications. The
OptiDIFF platform was developed from world-leading research undertaken at the University of Cambridge and has been demonstrated on a range of cell types. The client receives fully
differentiated rigorously QCed cell products which are genotype and phenotype verified in a highly relevant physiological background.